Cardinal Health (CAH) Tops Q1 EPS by 28c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Leerink Partners Raises Price Target on Cardinal Health (CAH) Following Conference Call
November 4, 2015 3:03 PM ESTLeerink Partners reiterated an Outperform rating on Cardinal Health (NYSE: CAH), and raised the price target to $105.00 (from $100.00), following the company's 1Q16 earnings conference call. The strong 49bp increase in pharmaceutical segment operating margin (to 2.61%) was driven by generic strength. F2016 pharmaceutical segment revenue is now expected to be in the... More
UBS Raises Price target on Cardinal Health (CAH) Following 1Q16 Conference Call
November 3, 2015 8:36 AM ESTUBS reiterated a Buy rating on Cardinal Health (NYSE: CAH), and raise the price target to $100.00 (from $97.00), following 1Q16 earnings call. On CAH's F1Q16 earnings call, the company provided some fresh input on the outlook for both brand and generic pricing. Regarding brand drug inflation, the rate in F1Q16 was slightly higher than the prior... More
